The need for a dedicated unit to tackle fungal disease in Africa.

‌

The major burden of serious invasive fungal infection is borne by low and middle income countries, particularly in sub-Saharan Africa, where around 50% of people diagnosed with invasive fungal infections die as a result of the infection.

To address this issue, the Universities of Exeter and Cape Town (UCT) have joined forces to create the world’s first international research centre for tackling fungal infections; the AFRICA CMM Unit, which opened in Cape Town in August 2017. The University of Exeter AFRICA CMM Unit, directed by Professor Gordon Brown, is based at UCT’s Institute of Infectious Disease and Molecular Medicine, headed by Professor Valerie Mizrahi, and will give our experts a centre of operations in Africa where they can work in collaboration with UCT experts to establish research programmes that can target the priority areas in fungal diseases that are relevant to the African continent.

Members

	Dr J. Claire Hoving is Associate Professor at the University of Cape Town and Wellcome Trust Intermediate Fellow in Public Health and Tropical Medicine and Senior Lecturer in the Division of Immunology, whose research aims at understanding host immune responses to HIV-related fungal infections. As an Associate Member of the Institute of Infectious Disease and Molecular Medicine and a contributing investigator of the Wellcome Centre for Infectious Diseases Research in Africa, her current major focus is understanding the immune response to Pneumocystis jirovecii, which is a common cause of pneumonia and death in patients with HIV/AIDS in Africa and which is estimated to kill over 250 000 worldwide every year. View profile >>
	Dr Rachael Dangarembizi is a Senior Lecturer and neuroscientist in the Department of Human Biology and the Neuroscience Institute at the University of Cape Town whose main research interest is neuroimmune responses to fungal infections. Her current research focuses on the inflammatory response to Cryptococcus neoformans infection in the brain.
	Dr Alisha Chetty is currently a UKRI/MRC African Research Leader Fellow in the Division of Immunology at the Institute of Infectious Disease and Molecular Medicine (IDM), and a contributing investigator of the Centre for Infectious Diseases Research in Africa (CIDRI-Africa), at the University of Cape Town, South Africa. Her research focuses on the influence of distal mucosal infections and inflammation, on female genital health and fertility.
	Dr A. Trevor Mnguni is currently a PhD candidate at the University of Cape Town and has specialist interests in pulmonary manifestations of HIV, bronchiectasis, interstitial lung disease, pulmonary vascular diseases and interventional pulmonology. He obtained his MB ChB from the University of KwaZulu-Natal in 2007. He later completed his FCP at Groote Schuur Hospital and the University of Cape Town. He graduated with a Master of Medicine (cum laude) from the University of Cape Town and trained and graduated as the first black pulmonologist from the University of Cape Town and Groote Schuur Hospital. He is the current Head of Department of Internal Medicine at Khayelitsha District Hospital, and a consultant and senior lecturer in the Division of Internal Medicine at Stellenbosch University and Tygerberg Hospital.

Workshops and Courses

Coming up.... 4th AIDS-related Mycoses Workshop | 10th - 12th July 2024 | Institute of Infection Disease and Molecular Medicine, University of Cape Town, South Africa.

More information at https://aidsmycoses.co.za/

3rd Workshop on AIDS-related Mycoses | 10th - 12th July 2019 | Institute of Infection Disease and Molecular Medicine, University of Cape Town, South Africa.

At the 2019 meeting, we focused on highlighting the continuing problem of advanced HIV and the contribution of mycoses to AIDS deaths. We expanded the range of disease covered and discussed the latest advances and the challenges facing our field. The programme included public health, novel prevention and treatment strategies, basic science of host-pathogen interactions, immunology, antifungal resistance and genomics.

Lecture and Practical Course in Medical Mycology | 10th - 14th December 2018 | Institute of Infection Disease and Molecular Medicine, University of Cape Town, South Africa.

Aims. The AFRICA CMM Unit, Institute Pasteur, Paris, and the AMBITION-cm Trial Consortium organised a week-long English-speaking course for scientists and clinicians aimed at providing a comprehensive overview of Medical Mycology. This lecture and practical course focused on the key fungal pathogens in Africa and covered the microbiological, immunological and clinical aspects of fungal diseases.

Lecture topics. Overview of host immunity and fungal pathogens, mechanisms of action of antifungal drugs and drug resistance, sessions of the physiopathology and management of the major pathogenic fungi present in Africa, with a specific focus on Cryptococcosis.

Practical topics. Basic techniques in the mycology laboratory, identification, diagnosis and histopathology of major pathogenic fungi, clinical case vignetter and how to be involved and manage clinical trials.

Audience. 32 attendees: 16 clinicians + 16 lab scientists / lab technicians

12 AMBITION sites delegates
4 DREAMM sites delegates
16 additional delegates (scientists or clinicians based in Africa – selected among 57 applications)

Teaching Team.

MRC Centre for Medical Mycology (MRC CMM): Prof Gordon Brown, Prof Adilia Warris, Prof Carol Munro.
Institut Pasteur, Paris: Prof Olivier Lortholary, Dr Alexandre Alanio, Dr Timothée Boyer Chammard, Dr Dea Garcia-Hermoso, Aude Sturny-Leclère.
Wellcome Centre for Infectious Disease Research in Africa (CIDRI-Africa) and AFRICA CMM Unit: Dr Claire Hoving, Prof Graeme Meintjes.
London School Hygiene and Tropical Medicine: Prof Joe Jarvis, Dr David Lawrence.
St Georges Hospital, University College London: Prof Tom Harrison, Dr Angela Loyse, Dr Tihana Bicanic.
National Institute for Communicable Diseases, Johannesburg: Dr Nelesh Govender.
Douala General Hospital/National Public Health Laboratory, Yaounde: Dr Elvis Temfack.

‌